8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported): August 9, 2007


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



           Delaware                      1-14120                52-1611421
(State or other jurisdiction   (Commission File Number)      (I.R.S. Employer
        of incorporation)                                    Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))






Item 2.02.  Results of Operations and Financial Condition

On August 9, 2007,  Blonder  Tongue  Laboratories,  Inc.  issued a press release
announcing its unaudited financial results for the second quarter ended June 30,
2007. A copy of the press release is attached to this Report as Exhibit 99.1 and
is incorporated herein by reference.  The information  disclosed in this report,
including  Exhibit  99.1  hereto,  is being  furnished  and  shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

Item 9.01.  Financial Statements and Exhibits

     (a) Not applicable


     (b) Not applicable


     (c) Not applicable


     (d) The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated August 9, 2007.







                                       2



                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By:  /s/ Eric Skolnik
                                         Eric Skolnik
                                         Senior Vice President
                                         and Chief Financial Officer

Date: August 9, 2007







                                       3







                                  EXHIBIT INDEX


         Exhibit No.                    Description

         Exhibit 99.1         Press Release of Blonder Tongue Laboratories, Inc.
                              dated  August  9,  2007  regarding  its  unaudited
                              financial  results  for  the  second quarter ended
                              June 30, 2007.




                                       4

EX-99

[LOGO]


                                                             One Jake Brown Road
                                                                   P.O. Box 1000
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353



   FOR IMMEDIATE RELEASE                   CONTACT:      James A. Luksch
                                                         Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000



               BLONDER TONGUE REPORTS 2007 SECOND QUARTER RESULTS

OLD  BRIDGE,  NEW JERSEY,  August 9, 2007 - Blonder  Tongue  Laboratories,  Inc.
(AMEX:  "BDR") today  announced  its sales and  earnings for the second  quarter
ended June 30, 2007.

Net sales  decreased  $1,431,000,  or 15.0%,  to  $8,091,000 in the second three
months of 2007 from  $9,522,000 in the second three months of 2006. The decrease
in sales is  primarily  attributed  to a decrease  in headend  and  interdiction
product  sales.  Headend  product  sales  were  $3,907,000  and  $4,806,000  and
interdiction product sales were $308,000 and $650,000 in the second three months
of 2007 and 2006, respectively.

Cost of goods sold  decreased to $5,712,000  for the second three months of 2007
from  $6,510,000  for the  second  three  months  of 2006,  but  increased  as a
percentage of sales to 70.6% from 68.4%.  The decrease was attributed  primarily
to a decrease in sales in the second  three  months of 2007 as compared to 2006,
offset by an increase in the provision for  inventory  reserves of $558,000.  Of
the 2.2%  increase in cost of goods sold as a percentage  of sales,  6.9%,  as a
percentage  of sales,  is  attributable  to the  increase in the  provision  for
inventory  reserves  offset by a decrease in cost of goods sold as percentage of
sales of 4.7% due to a more favorable product mix.

Loss from continuing  operations  after income taxes was $822,000 or $(0.13) per
share for the second  three  months of 2007  compared  to a loss of  $332,000 or
$(0.04) per share for the comparable period in 2006.

Commenting on the second quarter 2007 results,  James A. Luksch, Chief Executive
Officer,  said,  "Although our second  quarter sales were lower  compared to the
prior year, we did see improvement sequentially as our second quarter sales were
approximately 8% higher than the first quarter. We are continuing our efforts to
reduce operating expenses and expect to see annualized improvements in excess of
$1,000,000.  Our China  initiative  remains  on course  and we expect to realize
noticeable  benefits from reduced costs  beginning in the third quarter of 2007,
with further improvements continuing into 2008."

Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband  service  providers  in  the  multiple  dwelling  unit,   lodging  and
hospitality, and institutional cable markets. The Company designs, manufactures,
and  supplies a  comprehensive  line of  equipment  to deliver  video  (analog &
digital),  high speed data and voice services over integrated  coaxial and fiber
optic broadband networks today and over packet based, Internet protocol networks
of the future.  For more information  regarding  Blonder Tongue or its products,
please  visit the  Company's  Web site at  www.blondertongue.com  or contact the
Company directly at (732) 679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2006 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission are  incorporated  herein by reference.  The
words  "believe",  "expect",  "anticipate",  "should",  "project",  and  similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis only as of the date hereof.  Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  Blonder  Tongue's  actual
results may differ from the anticipated results or other expectations  expressed
in Blonder Tongue's "forward-looking" statements


                                     -MORE-




                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                  Three months ended          Six months ended
                                       June 30,                   June 30,
                               ------------------------- -----------------------
                               ------------ ------------ ----------- -----------
                                  2007         2006         2007       2006

Net sales                        $8,091       $9,522       $15,590    $19,479
Gross profit                      2,379        3,012         4,874      6,310
Earnings (loss) from
  operations                       (704)         (98)       (1,428)       464
Loss from continuing
  operations                       (822)        (332)       (1,664)       (15)
Loss from discontinued
  operations                        (59)         (72)          (59)      (197)
Net loss                          $(881)       $(404)      $(1,723)     $(212)
Basic and diluted loss
  per share from
  continuing operations          $(0.13)      $(0.04)       $(0.27)    $(0.02)
Basic and diluted loss
  per share from
  discontinued operations        $(0.01)      $(0.01)       $(0.01)    $(0.01)
Basic and diluted net loss
  per share                      $(0.14)      $(0.05)       $(0.28)    $(0.03)
Basic and diluted weighted
  average shares outstanding:     6,222        8,010         6,222      8,013


                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                           June 30,                December 31,
                                             2007                      2006
                                          (unaudited)

Current assets                               $14,173                 $14,942
Property, plant, and equipment, net            4,375                   4,537
Total assets                                  26,026                  27,222
Current liabilities                            5,491                   5,431
Long-term liabilities                          1,437                   1,559
Stockholders' equity                          19,098                  20,232

Total liabilities and stockholders' equity   $26,026                 $27,222




                                       ###


                                       2